Abstracts tagged "cerebrovascular disease and systemic lupus erythematosus (SLE)"

Abstract Number: 1082 • 2014 ACR/ARHP Annual Meeting
Risk of Intra Cranial Hemorrhage among Patients with Anti-Phospho-Lipid-Antibody (aPL) syndrome vs Systemic Lupus Erythematosus (SLE) in Stroke Population: A Nationwide Analysis
Tapan Mehta¹, Khushboo Sheth², Ronak Soni³, Sonam Puri² and Kathan Mehta⁴, ¹Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ²Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ³Internal Medicine, Government Medical College, Surat, India, ⁴Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA
Background/Purpose Central nervous system involvement is common in Systemic Lupus Erythematosus (SLE) and was first described in 1873. Though ischemic involvement is more common than…
Abstract Number: 658 • 2012 ACR/ARHP Annual Meeting
Up-Regulation of A Disintegrin and Metalloprotease with Thrombospondin Type I Repeats-13 Correlates with Ischemic Cerebrovascular Disease in Systemic Lupus Erythematosus Patients
Consuelo Lopez de Padilla¹, Molly Hein², Cynthia S. Crowson³, Christopher Choo⁴, Abigail B. Green³, Michelle Petri⁵, Hatice Bilgic⁶, Emily Baechler Gillespie⁶ and Ann M. Reed⁷, ¹Rheumatology/Immunology Research, Mayo Clinic, Rochester, MN, ²Mayo Clinic, Rochester, MN, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Division of Rheumatology, Mayo Clinic, Rochester, MN, ⁵Johns Hopkins University School of Medicine, Baltimore, MD, ⁶University of Minnesota Medical School, Minneapolis, MN, ⁷Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: ADAMTS13 (A Disintegrin-like And Metalloprotease with ThromboSpondin type 1 motif) belongs to a recently described group of metalloproteinase enzymes which possess proteoglycanase and anti-angiogenic…